Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat(®) in Asthma Using Standardized Sample-Contamination Avoidance

Background: This study was conducted to confirm the 24-hour bronchodilator efficacy and pharmacokinetic profile of once-daily tiotropium Respimat(®) 5 μg add-on to inhaled corticosteroids (ICS) in adults with symptomatic asthma. It used a trial protocol designed to minimize the risk of pharmacokinet...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Aerosol Med Pulm Drug Deliv
Huvudupphovsmän: Beeh, Kai-Michael, Kirsten, Anne-Marie, Dusser, Daniel, Sharma, Ashish, Cornelissen, Piet, Sigmund, Ralf, Moroni-Zentgraf, Petra, Dahl, Ronald
Materialtyp: Artigo
Språk:Inglês
Publicerad: Mary Ann Liebert, Inc. 2016
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073218/
https://ncbi.nlm.nih.gov/pubmed/26859538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2015.1260
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk